Opus Genetics (IRD) Interest Coverage Ratio Growth (3y) (2014 - 2022)
Opus Genetics (IRD) Interest Coverage Ratio Growth (3y) (2014 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | Opus Genetics | 3.27 Mn | -56.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -2,538.22% |
| Mar 31, 2022 | -2,341.46% |
| Dec 31, 2021 | -134.61% |
| Dec 31, 2020 | 76.52% |
| Sep 30, 2020 | 20.31% |
| Jun 30, 2020 | 31.77% |
| Mar 31, 2020 | 9.89% |
| Dec 31, 2019 | 26.44% |
| Sep 30, 2019 | 14.81% |
| Jun 30, 2019 | 8.91% |
| Mar 31, 2019 | 7.71% |
| Dec 31, 2018 | -8.41% |
| Sep 30, 2018 | 1.29% |
| Jun 30, 2018 | 0.87% |
| Mar 31, 2018 | -7.15% |
| Dec 31, 2017 | 4.22% |
| Sep 30, 2017 | 4.39% |
| Jun 30, 2017 | 7.80% |
| Mar 31, 2017 | 3.01% |
| Dec 31, 2016 | -13.77% |